Concepedia
Statistics
Publications
25
Citations
885
H-Index
17
Active since
2003
Affiliations
Tokai University(Current)
Japanese Red Cross Nagoya Daini Hospital
Aichi Cancer Center
National Hospital Organization
Kyoto Prefectural University of Medicine
Ken Ohmachi is an author at Tokai University specializing in medicine, oncology, and hematologic malignancy therapy.
Publications per year
2003–2022
Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Ken Ohmachi, Nozomi Niitsu, Toshiki Uchida et al. · Journal of Clinical Oncology · 2013 · 170 citations
Medicine, Oncology, Pharmacotherapy +15
Clinical outcome of Epstein–Barr virus‐positive diffuse large B‐cell lymphoma of the elderly in the rituximab era
Ai Sato, Naoya Nakamura, Minoru Kojima et al. · Cancer Science · 2014 · 68 citations · Full text
Medicine, Hematology, Oncology +14
Multicenter phase II study of bendamustine for relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma
Ken Ohmachi, Kiyoshi Ando, Michinori Ogura et al. · Cancer Science · 2010 · 67 citations · Full text
Medicine, Oncology, Pharmacology +15
Phase I study of tirabrutinib (<scp>ONO</scp>‐4059/<scp>GS</scp>‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan
Wataru Munakata, Kiyoshi Ando, Kiyohiko Hatake et al. · Cancer Science · 2019 · 51 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation
Kosuke Tsuboi, Kenji Kishi, Ken Ohmachi et al. · Bone Marrow Transplantation · 2003 · 48 citations
Medicine, Hematology, Surgery +9
1–5 of 25